1986
DOI: 10.1016/0024-3205(86)90409-1
|View full text |Cite
|
Sign up to set email alerts
|

Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

11
127
0

Year Published

1988
1988
1997
1997

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 366 publications
(138 citation statements)
references
References 7 publications
11
127
0
Order By: Relevance
“…M 2 and M 3 receptors are primarily found in lower brain areas and in peripheral effector argans such as heart (M 2 ), smooth muscle (M 3 ) and glands (M 3 ) and display low affinity for pirenzepine. They can be distinguished by the use of selective antagonists such as methoctramine and AF-DX 116 (M 2 > M 1 > M 3 ) (Melchiorre et al 1987;Hammer et al 1986;Micheletti et al 1987), himbacine (M 1 ~ M 2 > M 3 ) (Gilani and Cobbin 1986;Lazareno and Roberts 1989), sila-hexocyclium (M 1 ~ M 3 > M 2 ) Waelbroeck et al 1989), 4-DAMP and hexahydro-sila-difenidol (M 3 ::? :: M 1 > M 2 ) (Barlow et al 1976;Mutschier and Lambrecht 1984;.…”
Section: Introductionmentioning
confidence: 99%
“…M 2 and M 3 receptors are primarily found in lower brain areas and in peripheral effector argans such as heart (M 2 ), smooth muscle (M 3 ) and glands (M 3 ) and display low affinity for pirenzepine. They can be distinguished by the use of selective antagonists such as methoctramine and AF-DX 116 (M 2 > M 1 > M 3 ) (Melchiorre et al 1987;Hammer et al 1986;Micheletti et al 1987), himbacine (M 1 ~ M 2 > M 3 ) (Gilani and Cobbin 1986;Lazareno and Roberts 1989), sila-hexocyclium (M 1 ~ M 3 > M 2 ) Waelbroeck et al 1989), 4-DAMP and hexahydro-sila-difenidol (M 3 ::? :: M 1 > M 2 ) (Barlow et al 1976;Mutschier and Lambrecht 1984;.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, different sensitivities to pertussis toxin of the cellular responses mediated by individual mAChR subtypes suggest that the response induced by mAChR I or mAChR III and that induced by mAChR II or mAChR IV occur through distinct G-proteins [5,10,11]. The antagonist binding properties of individual mAChR subtypes expressed in Xenopus oocytes [2,3,12] show that mAChR I, mAChR II and mAChR III correspond most closely to the pharmacologically defined M1 (I), M2 cardiac (II) and M2 glandular (III) subtypes [13][14][15], respectively. This, together with the differential tissue distribution of the mRNAs encoding the individual mAChR species [2,[16][17][18][19], indicates that the mAChR heterogeneity in tissues with respect to antagonist binding is attributable to the presence of distinct mAChR gene products by themselves or in various combinations.…”
Section: Introductionmentioning
confidence: 99%
“…4 -6 M 2 receptors, with a low affinity for pirenzepine and a high affinity for AF-DX 116, are typical of eardiac tissues. 7 They show a .low affini ty for 4-DAMP and hexahydro-sll adifenidol. "-6·8·9 M 3 receptors have low affinities for pirenzepine and AF-DX 116, and high affinities for 4-DAMP10 and hexahydro-sila-difenidol.…”
Section: Introductionmentioning
confidence: 99%